Over 200 GLP1 obesity programs are in development today. More than 300 PD1/PDL1 cancer programs exist. Greater than 150 programs target each of CD19 and KRAS. …
Biotech Newsroom
-
-
AI therapists could flatten humanity into patterns of prediction, and so sacrifice the intimate, individualized care that is expected of traditional human therapists. “The logic of …
-
Besides the expansion of its fermentation capacity to 5,000L, the CDMO added a state of the art process development laboratory to its new production site in …
-
A newly engineered hydrogel could offer a longer-lasting, minimally invasive way to treat vocal cord injuries. Researchers at McGill University have developed a new hydrogel that …
-
<div><p paraid="1954319879" paraeid="{d98d2f39-2796-42e8-a9a8-8ee3c61b07fd}{11}"><strong>By Bio-IT World Staff </strong></p></div><div><p paraid="1826323498" paraeid="{d98d2f39-2796-42e8-a9a8-8ee3c61b07fd}{17}"><strong>December 29, 2025</strong> | In the Bio-IT World year, focus continues to be paid to pharma’s research choices and the latest in …
-
Gene Therapy
Codon-optimized human Smad7 gene therapy enhances skeletal muscle mass and function in a murine model of Duchenne muscular dystrophy
Mauro VP. Codon optimization in the production of recombinant biotherapeutics: potential risks and considerations. BioDrugs. 2018;32:69–81. Article CAS PubMed Google Scholar Kames J, Alexaki A, Holcomb …
-
Clinical Data
TROG’s inaugural Km’s for Cancer Research brings community together to support our work
LATEST NEWS: 9 December 2025 As we wrap up our inaugural Km’s for Cancer Research challenge, we want to thank the incredible community who helped make …
-
Word Count: 4,283 words, Reading Time: 20 minutes. Not financial advice, do your own due diligence, for entertainment purposes only. Subscribers: Substack is telling me this …
-
InTheTech is charting a new course in digital cognitive health, seeking to bring clinically validated therapies out of the clinic and into everyday life. From a …
-
By Ram Aiyar, CEO of Korro Bio, as part of the From The Trenches feature of LifeSciVC It has been an extraordinary journey so far and …